SignalCorporate
NGS Reference Materials Market Insights and Competitive Landscape - Forecast to 2036 | Total Revenue to Reach $904.1 Million as Liquid Biopsy and IVD-Grade Standards Drive 10.7% CAGR
Forecast cites $904.1 million revenue and 10.7% CAGR driven by liquid biopsy and IVD-grade standards.
Context
What happened: ResearchAndMarkets.com added a report forecasting the global NGS reference materials market, citing clinical sequencing demand, assay validation needs, and IVD-grade standards as growth drivers.
Key numbers: Market valued at USD 293.4 million in 2025, estimated at USD 327.3 million in 2026,
Why it matters: Laboratories must validate assays before patient testing and after changes to reagents, instruments, or pipelines, making quality controls a recurring purchase. Growth is constrained by scarce residual patient specimens and budget pressures at smaller laboratories.
Market: -3.4% today ($193.75), +44.2% YTD, 0.2x vol — as of 17:17 UTC
What changed
ResearchAndMarkets.com added a report forecasting the global NGS reference materials market, citing clinical sequencing demand, assay validation needs, and IVD-grade standards as growth drivers.
Why it matters
Laboratories must validate assays before patient testing and after changes to reagents, instruments, or pipelines, making quality controls a recurring purchase. Growth is constrained by scarce residual patient specimens and budget pressures at smaller laboratories.
Market: -3.4% today ($193.75), +44.2% YTD, 0.2x vol — as of 17:17 UTC